Phyzix Set to Debut at The Car Wash Show in Vegas
Phyzix brings 40+ years of car wash chemistry expertise to Vegas with bold solutions built to boost operator performance and profit.
STATESVILLE, NC, UNITED STATES, April 15, 2025 / EINPresswire.com / -- Phyzix Chemicals, the newest name redefining performance chemistry in the car wash industry, will officially debut at The Car Wash Show in Las Vegas on April 26, 2025. Designed by industry veterans with over 40 years of combined experience, Phyzix offers a bold, results-driven approach to car wash chemistry—focused entirely on helping operators clean better, perform stronger, and profit more.
Unlike typical chemical suppliers, Phyzix was created by chemistry-obsessed professionals who've spent decades in the trenches with car wash operators. That real-world experience has been converted into a full suite of premium chemical solutions and backroom systems that are custom-built to elevate every step of the wash process—from pre-soak to final shine.
'We're not just here to supply chemicals—we're here to supercharge results,' said Anthony Wilson, VP of Sales at Phyzix Chemicals. 'Chemistry is our religion, and our mission is simple: help operators boost performance, streamline their operations, and ultimately increase their profit per car.'
What Makes Phyzix Different?
At the heart of Phyzix is an unwavering commitment to practical innovation and measurable performance. The product line includes:
Graphene-Infused Top Packages: Cutting-edge protection and shine powered by polymer and siloxane technology for hydrophobic performance and customer satisfaction.
Custom Fragrance Systems: Scents that leave lasting impressions—designed to enhance the wash experience and drive loyalty from first-time customers to long-time members.
Core Cart Backroom System: A modular, plug-and-play chemical management system that reduces waste, saves space, and delivers ultra-consistent results.
Tailored Programs: Every wash is different. Phyzix creates chemical solutions based on operator needs, wash types, and environmental factors, ensuring maximum efficiency and ROI.
Experience It First at Booth #2863
Visitors to The Car Wash Show will be the first to experience Phyzix's innovations in action. The Phyzix team will be offering hands-on product demos, performance consultations, and free resources to help operators identify profit leaks and implement smarter chemical strategies.
'We know the challenges operators face—overdosing, underperforming chemistry, backroom headaches,' said Wilson. 'That's why we built Phyzix. We're here to take the guesswork out of chemistry and help operators get more out of every gallon, every wash, every customer.'
Discover the Future of Chemistry
Phyzix isn't just a product line—it's a partner in performance. Whether you're an independent operator or managing multiple sites, Phyzix offers the expertise, tools, and support to level up your entire wash operation.
Meet the team at Booth #2863 and discover how better chemistry leads to bigger profits.
Learn more at www.phyzix.com
Media Contact:
Ygor Brito
Marketing Manager, Phyzix
[email protected]
Ygor Brito
Phyzix
email us here
Visit us on social media:
Facebook
X
LinkedIn
Instagram
Legal Disclaimer:
EIN Presswire provides this news content 'as is' without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 days ago
- Yahoo
Insider predicts which New York Jets stars receive contract extensions, including Sauce Gardner
The New York Jets are a team in transition led by first-year head coach Aaron Glenn and general manager Darren Mougey. With a roster centered around a young core of Garrett Wilson, Breece Hall and Sauce Gardner, only a few may receive contract extensions from the new regime. Asked to weigh in on the situation, Albert Breer of Sports Illustrated said he thinks Gardner and Wilson would receive real consideration for extensions right now and both deals could get done. However, a new deal for Hall isn't nearly as likely. Advertisement Related: New York Jets' Allen lazard's stance on playing for Pittsburgh Steelers, Aaron Rodgers 'If I had to guess, Sauce Gardner and Garrett Wilson would be considered for extensions now—and I do think there's a chance at least Gardner and maybe Wilson still get done. With Breece Hall, I think they'd explore it, but signing a back long-term can be tricky. I think with Johnson coming off an injury, they'll probably play it out, knowing they can tag him if he plays to his potential. Sports Illustrated's Albert Breer on future contract extensions for New York Jets stars Both Wilson and Gardner would likely command deals that would make them among the highest-paid NFL players at their respective positions. Even coming off a down year, Gardner could push for $30 million annually given his track record as a two-time All-Pro selection. Garrett Wilson stats (2024): 101 receptions, 1,104 receiving yards, 7 touchdowns While Wilson hasn't received a Pro Bowl selection since being selected with the 10th overall pick in the 2022 NFL Draft, he's delivered three consecutive 1,000-yard seasons despite poor quarterback play. As with cornerbacks, the going rate for No. 1 receivers is now pushing toward $30 million annually. Related: Jets insider sheds light on likely cost of Sauce Gardner contract extension Sauce Gardner stats (2024): 86.9 QB rating, 541 receiving yards, 15.4 yards per completion allowed on 58 targets in 15 games Advertisement Wilson and Gardner have both showcased the talent and durability to be building blocks for the Jets' future. The same can't be said for Hall. While he is coming off consecutive campaigns with over 1,300 scrimmage yards, long-term durability remains a concern and he ranked 39th in true yards per carry (4.0) last season. Furthermore, Hall seemed to be floated in trade rumors this offseason and the Jets at the very least scouted the rookie running back class. While contract extensions seem likely for Gardner and Wilson, Hall will have to prove himself to receive a long-term deal. Related: New York Jets reportedly could target specific position in free agency Related Headlines
Yahoo
2 days ago
- Yahoo
The Berwyn Group Appoints Adam Wilson as General Manager of Healthcare
Veteran Leader Brings Deep Industry Expertise to Advance Berwyn's Healthcare Strategy INDEPENDENCE, Ohio, June 13, 2025 /PRNewswire/ -- The Berwyn Group (Berwyn), the leader in death audit, locate services and population management, is pleased to announce the hiring of Adam Wilson as General Manager of Healthcare. Wilson brings extensive healthcare industry experience that will further strengthen Berwyn's commitment to excellence and growth. Berwyn offers an end-to-end suite of industry-leading death audit and locate solutions that enable pension and health plan administrators to eliminate costly overpayments, maximize efficiency, meet regulatory requirements, and connect policyholders, participants and beneficiaries to the funds they deserve. More than 2,000 corporate, union and government clients use Berwyn's flagship services, CertiDeath® and CertiCensus®. Wilson joins Berwyn with a distinguished career that spans almost 17 years at UnitedHealthcare, where he held several leadership roles including Vice President of Workforce Planning, Chief of Staff to the COO, and Vice President of Medicare Part D products. "We are thrilled to welcome Adam to the team," said John Bikus, President of Berwyn. "His strategy, proven leadership, and deep industry knowledge will be invaluable as we continue to grow in the healthcare industry." In his new role, Wilson will be responsible for leading Berwyn's strategic expansion into the healthcare market. He will be focusing on aligning Berwyn's solutions to the healthcare payer and provider business cycle needs while also extending the Berwyn reach to healthcare-related supporting partners, vendors, and industry trade groups. "I'm eager to join an organization positioned for rapid growth through industry-leading capabilities," said Wilson. "I look forward to collaborating with the talented team at Berwyn to deliver quick wins, strategic expansion into healthcare, and contribute to the company's continued success." About The Berwyn Group The Berwyn Group is the leader in population data management, offering the industry's most trusted and effective death audit and locate solutions, with an unmatched dedication to innovation, security, and generating outcomes. Acquired by Longevity Holdings in 2023, The Berwyn Group offers an end-to-end suite of industry-leading solutions including CertiDeath® Paragon™, CertiDeath®, CertiCensus®, CertiSearch® and BeneSearch®. Connecting leading-edge technology and data with best-in-class human ingenuity, Berwyn helps bridge the gap between pensions and their participants, insurance companies and their policyholders, third-party administrators and public entities with Medicaid recipients. For more information, visit Media Contact Karlene Gilmore Director of Marketing kgilmore@ View original content: SOURCE The Berwyn Group, Inc. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
2 days ago
- Yahoo
TELO Rises on Promising Telomir-1 Preclinical Results
Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) is among the 10 Best Growth Stocks Under $100 to Buy Now. On Wednesday, Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) revealed that its leading product, Telomir-1, showcased a marked improvement in the neurological, liver, and kidney symptoms observed in a preclinical animal model of Wilson's disease. In a zebrafish model mimicking Wilson's disease, the drug showed substantial dose-dependent improvements, including a decrease in tremors, a normal swimming behavior, and a 50% reduction in copper accumulation in liver tissue. It also led to better liver and kidney histopathology while restoring key biomarkers. As Dr. Angel, Chief Scientific Advisor at Telomir Pharmaceuticals, Inc. (NASDAQ:TELO), mentioned, 'These recent findings establish Telomir-1 as a potent disease-modifying compound in a clinically relevant model of Wilson's disease.' A biopharmaceutical research laboratory filled with scientists, illuminated by the glow of their equipment. With a market capitalization of $59.079 million, the company is also positioning its drug through IND-enabling studies, with plans to submit its first IND for a rare disease by the year's end, followed by human trials in the first half of the next year. Analysts have set a price target of $15.50 for Telomir Pharmaceuticals, Inc. (NASDAQ:TELO), implying an upside of a whopping 688%. These well-structured plans highlight the company's position to lead the global market in the years ahead. Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) is a pre-clinical stage biopharmaceutical company that emphasizes the reversal of oxidative stress, cellular protection, and regulatory mechanisms. Incorporated in 2021, this Florida-based company is designing and developing products to address the causes of rare diseases. While we acknowledge the potential of TELO as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
